Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Mallinckrodt
Harvard Business School
Dow
Medtronic

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Homatropine methylbromide; hydrocodone bitartrate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for homatropine methylbromide; hydrocodone bitartrate and what is the scope of patent protection?

Homatropine methylbromide; hydrocodone bitartrate is the generic ingredient in five branded drugs marketed by Genus Lifesciences, Abhai Llc, Actavis Mid Atlantic, Breckenridge, Hi Tech Pharma, Ivax Sub Teva Pharms, Novel Labs Inc, Paddock Llc, Torrent, Wockhardt Bio Ag, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for homatropine methylbromide; hydrocodone bitartrate. Ten suppliers are listed for this compound.

Summary for homatropine methylbromide; hydrocodone bitartrate
Pharmacology for homatropine methylbromide; hydrocodone bitartrate
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for homatropine methylbromide; hydrocodone bitartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 203535-001 Feb 13, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
Hi Tech Pharma HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040613-001 Feb 8, 2008 AA RX No Yes   Start Trial   Start Trial   Start Trial
Actavis Elizabeth HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 040295-001 Dec 1, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Avanthi Inc HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 207176-001 Aug 7, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
Genus Lifesciences HYCODAN homatropine methylbromide; hydrocodone bitartrate TABLET;ORAL 005213-001 Jul 26, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040285-001 Jul 19, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Abhai Llc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 207487-001 Feb 21, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Colorcon
Mallinckrodt
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.